Reference
Fu M, et al. Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018. JAMA Internal Medicine : 18 Oct 2021. Available from: URL: http://doi.org/10.1001/jamainternmed.2021.5983
Rights and permissions
About this article
Cite this article
Spending on new oral cancer drugs with no documented OS benefit high in the USA. PharmacoEcon Outcomes News 890, 27 (2021). https://doi.org/10.1007/s40274-021-08150-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08150-x